0000899243-20-003371.txt : 20200205
0000899243-20-003371.hdr.sgml : 20200205
20200205180204
ACCESSION NUMBER: 0000899243-20-003371
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200203
FILED AS OF DATE: 20200205
DATE AS OF CHANGE: 20200205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Vantage I, L.P.
CENTRAL INDEX KEY: 0001765253
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39200
FILM NUMBER: 20580162
BUSINESS ADDRESS:
STREET 1: ONE SANSOME, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: (415) 801-8100
MAIL ADDRESS:
STREET 1: ONE SANSOME, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
FORMER NAME:
FORMER CONFORMED NAME: Versant Opportunity Fund I, L.P.
DATE OF NAME CHANGE: 20190117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Voyageurs I, L.P.
CENTRAL INDEX KEY: 0001745960
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39200
FILM NUMBER: 20580163
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 415-801-8100
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Venture Capital VI, L.P.
CENTRAL INDEX KEY: 0001687880
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39200
FILM NUMBER: 20580164
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: (415) 801-8100
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Voyageurs I Parallel, L.P.
CENTRAL INDEX KEY: 0001745961
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39200
FILM NUMBER: 20580165
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 415-801-8100
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Black Diamond Therapeutics, Inc.
CENTRAL INDEX KEY: 0001701541
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 139 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-417-5868
MAIL ADDRESS:
STREET 1: 139 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Aset Therapeutics, Inc.
DATE OF NAME CHANGE: 20170321
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-03
0
0001701541
Black Diamond Therapeutics, Inc.
BDTX
0001687880
Versant Venture Capital VI, L.P.
ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO
CA
94104
0
0
1
0
0001745961
Versant Voyageurs I Parallel, L.P.
ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO
CA
94104
0
0
1
0
0001745960
Versant Voyageurs I, L.P.
ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO
CA
94104
0
0
1
0
0001765253
Versant Vantage I, L.P.
ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO
CA
94104
0
0
1
0
Common Stock
2020-02-03
4
C
0
4973787
A
5305372
D
Common Stock
2020-02-03
4
C
0
380817
A
380817
I
See footnote
Common Stock
2020-02-03
4
C
0
1277111
A
1277111
I
See footnote
Common Stock
2020-02-03
4
C
0
653412
A
5958784
D
Common Stock
2020-02-03
4
C
0
150085
A
530902
I
See footnote
Common Stock
2020-02-03
4
C
0
503327
A
1780438
I
See footnote
Common Stock
2020-02-03
4
C
0
454548
A
6413332
D
Common Stock
2020-02-03
4
C
0
104407
A
635309
I
See footnote
Common Stock
2020-02-03
4
C
0
350141
A
2130579
I
See footnote
Common Stock
2020-02-03
4
C
0
810522
A
810522
I
See footnote
Common Stock
2020-02-03
4
P
0
79013
19.00
A
2209592
I
See footnote
Common Stock
2020-02-03
4
P
0
23560
19.00
A
658869
I
See footnote
Common Stock
2020-02-03
4
P
0
396082
19.00
A
6809414
D
Common Stock
2020-02-03
4
P
0
396081
19.00
A
1206603
I
See footnote
Series A Preferred Stock
2020-02-03
4
C
0
15000000
D
Common Stock
4973787
0
D
Series A Preferred Stock
2020-02-03
4
C
0
1148474
D
Common Stock
380817
0
I
See Footnote
Series A Preferred Stock
2020-02-03
4
C
0
3851526
D
Common Stock
1277111
0
I
See Footnote
Series B Preferred Stock
2020-02-03
4
C
0
1970572
D
Common Stock
653412
0
D
Series B Preferred Stock
2020-02-03
4
C
0
452630
D
Common Stock
150085
0
I
See Footnote
Series B Preferred Stock
2020-02-03
4
C
0
1517940
D
Common Stock
503327
0
I
See Footnote
Series C Preferred Stock
2020-02-03
4
C
0
1370833
D
Common Stock
454548
0
D
Series C Preferred Stock
2020-02-03
4
C
0
314873
D
Common Stock
104407
0
I
See Footnote
Series C Preferred Stock
2020-02-03
4
C
0
1055960
D
Common Stock
350141
0
I
See Footnote
Series C Preferred Stock
2020-02-03
4
C
0
2444382
D
Common Stock
810522
0
I
See Footnote
Upon the closing of the Issuer's initial public offering, all shares of Series A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-3.01581 basis. The Series A Preferred Stock had no expiration date.
Shares held by Versant Venture Capital VI, L.P. ("Versant VI"). Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports.
Shares held by Versant Voyageurs I Parallel, L.P. ("Versant I Parallel"). Versant Voyageurs I GP, L.P. ("Versant Voyageurs I GP LP") is the general partner of Versant I Parallel. Versant Ventures VI GP, L.P. is the general partner of Versant Voyageurs I GP LP. Versant Ventures VI GP-GP is the general partner of Versant Ventures VI GP. Bradley J. Bolzon, is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant I Parallel; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports.
Shares held by Versant Voyageurs I, L.P.("Versant Voyageurs I"). Versant Voyageurs I GP Company ("Versant Voyageurs I GP") is the general partner of Versant Voyageurs I. Bradley J. Bolzon is may be deemed to share voting and dispositive power over the shares held by Versant Voyageurs I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports.
Upon the closing of the Issuer's initial public offering, all shares of Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-3.01581 basis. The Series B Preferred Stock had no expiration date.
Upon the closing of the Issuer's initial public offering, all shares of Series C Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-3.01581 basis. The Series C Preferred Stock had no expiration date.
Shares held by Versant Vantage I, L.P. ("Versant Vantage I"). Versant Vantage I GP, L.P. ("Versant Vantage I GP LP") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC ("Versant Vantage I GP GP") is the general partner of Versant Vantage I GP L.P. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports.
On February 3, 2020, Versant Voyageurs I purchased 79,013 shares of Common Stock of the Issuer at a price of $19.00 per share pursuant to an underwritten public offering.
On February 3, 2020, Versant I Parallel purchased 23,560 shares of Common Stock of the Issuer at a price of $19.00 per share pursuant to an underwritten public offering.
On February 3, 2020, Versant VI purchased 396,082 shares of Common Stock of the Issuer at a price of $19.00 per share pursuant to an underwritten public offering.
On February 3, 2020, Versant Vantage I purchased 396,081 shares of Common Stock of the Issuer at a price of $19.00 per share pursuant to an underwritten public offering.
/s/ Versant Venture Capital VI, L.P. By: Versant Ventures VI GP, L.P. Its: General Partner By: Versant Ventures VI GP-GP, LLC By: Robin L. Praeger Its: Managing Director
2020-02-05
/s/ Versant Voyageurs I Parallel, L.P. By: Versant Voyageurs I GP, L.P. Its: General Partner By: Versant Ventures VI GP, L.P. Its: General Partner By: Versant Ventures VI GP-GP, LLC By: Robin L. Praeger Its: Managing Director.
2020-02-05
/s/ Versant Voyageurs I, L.P. By: Versant Voyageurs I GP Company Its: General Partner By: Robin L. Praeger Its: President.
2020-02-05
/s/ Versant Vantage I, LP By: Versant Vantage I GP, L.P. Its: General Partner By: Versant Vantage I GP-GP, LLC Its: General Partner By: Robin L. Praeger Its: Managing Director
2020-02-05